Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (새로운 창 열기)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Source‎: Eur J Haematol 1996;56(5):326-8.

Indexed‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (새로운 창 열기)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (새로운 창 열기)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Source‎: Acta Haematol 1995;94(3):128-34.

Indexed‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (새로운 창 열기)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (새로운 창 열기)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Source‎: Haematologica 2006;91(8):1076-83.

Indexed‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (새로운 창 열기)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (새로운 창 열기)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Source‎: J Obstet Gynaecol 2007;27(1):82-3.

Indexed‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (새로운 창 열기)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (새로운 창 열기)

Wang SW, Badami CD, Deitch EA.

Source‎: Am Surg 2009;75(12):1175-8.

Indexed‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (새로운 창 열기)